Analysis of the effectiveness of glioblastoma immunotherapy using gamma-delta T cells
2019/35/B/NZ6/03748
Keywords
Descriptors
- NZ6_001: Odporność swoista i nieswoista
- NZ5_007: Leczenie chorób człowieka
- NZ1_007: Inżynieria komórkowa
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii
Voivodeship: dolnośląskie
Principal investigator (from the host institution)
dr hab. Grzegorz Jacek Chodaczek
Number of co-investigators in the project: 9
Call
OPUS 18 – announced on 2019-09-16
- Amount awarded
- 3 374 760 PLN
- Project start date
- 2020-07-28
- Project end date
- 2026-07-27
- Project duration
- 72 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary Ovarian Cancer Cells and Their Therapeutic Opportunities
- Authors:
- Szyposzynska, A.; Bielawska-Pohl, A.; Murawski, M.; Sozanski, R.; Chodaczek, G.; Klimczak, A.
- Academic press:
- Int. J. Mol. Sci. (year: 2023, volume: 24(21), pages: 15862), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms242115862 – link to the publication